Anti‐CRLF2 Antibody‐Armored Biodegradable Nanoparticles for Childhood B‐ALL
Rekha Raghunathan(The University of Texas at San Antonio Health Science Center), William E. Haskins(Gryphon Scientific (United States)), Thomas G. Forsthuber(The University of Texas at San Antonio), Kranthi Kancharla(The University of Texas at San Antonio), Swetha Mahesula(The University of Texas at San Antonio Health Science Center), Yeshwant Lal Avinash Jadhav(The University of Texas at San Antonio Health Science Center), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Robert J. Nadeau, Preethi Janardhanan(The University of Texas at San Antonio), Colleen M. Witt(The University of Texas at San Antonio), Robert L. Cook(The University of Texas at San Antonio), Germán Plascencia‐Villa(The University of Texas at San Antonio)
Cited by 8
Related Papers
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
|Nature|1993|1.1k
Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
|The Journal of Experimental Medicine|1996|426
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
|EBioMedicine|2023|275
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer
|European Urology|2018|224
Strain-Dependent Variation in 18S Ribosomal DNA Copy Numbers in <i>Aspergillus fumigatus</i>
|Journal of Clinical Microbiology|2009|197